2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Sleep Initiation and Maintenance Disorders
30
Neoplasms
22
Breast Neoplasms
20
Anxiety Disorders
13
Depression
12
Prostatic Neoplasms
8
Fatigue
8
Lung Neoplasms
5
Motor Activity
4
Lymphoma
4
Weight Loss
3
Uterine Cervical Neoplasms
3
Ovarian Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Chronic Pain
3
Smoking Cessation
2
Sleep Wake Disorders
2
Pain
2
Overweight
2
Obesity
2
Nervous System Diseases
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Glioma
2
Glioblastoma
2
Cognitive Dysfunction
2
Carcinoma, Non-Small-Cell Lung
2
Weight Gain
1
Uterine Neoplasms
1
Interventions
olaparib
9
Carboplatin
3
talazoparib
1
pembrolizumab
1
liposomal doxorubicin
1
iniparib
1
Trabectedin
1
Surveys and Questionnaires
1
Secretin
1
Paclitaxel
1
Genotype
1
Genetic Counseling
1
Demography
1
Data Collection
1
Counseling
1
Cognitive Behavioral Therapy
1
Biopsy, Fine-Needle
1
ABT-767
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fanconi Anemia, Complementation Group D1
×
Cognitive Behavioral Therapy
×
Clear all
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled